Illumina and NVIDIA collaborate to decode biology and propel precision health | PR Newswire [Video]

Collaboration combines Illumina’s sequencing technologies and Illumina Connected Software with NVIDIA tools to develop biological foundation models

, /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN), a global leader in genomic sequencing and analysis, today announced it is collaborating with NVIDIA to advance technology platforms for the analysis and interpretation of multiomic data, accelerating progress in clinical research, genomics AI development, and drug discovery.

To optimize analysis of the vast amounts of data involved in multiomic research, Illumina and NVIDIA will combine advancements in AI with multiomic data at scale. Leveraging Illumina’s leading sequencing technology and informatics tools alongside NVIDIA’s leading AI technology, the partnership aims to accelerate drug discovery and clinical development, delivering powerful tools to help pharmaceutical companies identify new and better drug targets.

Illumina’s leading sequencing technology—as well as its menu of DRAGEN-powered multiomics offerings, genomics AI tools, and Illumina Connected Analytics platform—has streamlined genomic data generation and analysis. …